Calithera Biosciences, Inc
CALA
CALA was delisted on the 1st of February, 2023.
40 hedge funds and large institutions have $27.1M invested in Calithera Biosciences, Inc in 2016 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 11 increasing their positions, 10 reducing their positions, and 12 closing their positions.
10% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 10
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
9% less funds holding
Funds holding: 44 → 40 (-4)
23% less capital invested
Capital invested by funds: $35.2M → $27.1M (-$8.06M)
33% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
First Eagle Investment Management
New York
|
+$1.07M |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
+$1.05M |
| 3 |
Renaissance Technologies
New York
|
+$298K |
| 4 |
DTL
Dynamic Technology Lab
Singapore
|
+$186K |
| 5 |
D.E. Shaw & Co
New York
|
+$143K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$5.29M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
-$450K |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$198K |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$162K |
| 5 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$150K |
CALA Hedge Fund Activity: Q3 2016 in Review
40 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Calithera Biosciences, Inc (CALA) for Q3 2016, worth a combined $27.1M — down 23% from $35.2M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of CALA and 8 opened new positions — a net loss of 4 holders — while 10 trimmed existing stakes and 11 added.
The largest buyer was First Eagle Investment Management, adding an estimated $1.07M. The largest seller was Fidelity Investments, cutting an estimated $5.29M.
- 40 institutional investors held Calithera Biosciences, Inc (CALA) as of Q3 2016, down from 44 in Q2 2016.
- Funds reported $27.1M of Calithera Biosciences, Inc stock for Q3 2016, down 23% quarter-over-quarter.
- 8 funds opened new Calithera Biosciences, Inc positions in Q3 2016 and 12 closed out, a net change of -4 holders.
- The largest Calithera Biosciences, Inc buyer in Q3 2016 was First Eagle Investment Management, an estimated $1.07M added.
- The largest Calithera Biosciences, Inc seller in Q3 2016 was Fidelity Investments, an estimated $5.29M sold.
Based on aggregated 13F filings for Q3 2016.